International Flavors & Fragrances Inc.

This synthesis rests on the 2025 annual figures, the Q1 2026 10-Q excerpt, and the 2025 risk-factor text. No forensic scores are on file for IFF, so no Beneish M-Score, Piotroski F-Score, Altman Z-Score, or Fog Index reading is discussed here, and this page should not be read as a score-based assessment. For context, the Beneish M-Score is a screen for patterns that sometimes accompany earnings manipulation and is a flag for closer reading, not proof. The Piotroski F-Score counts financial-health signals, the Altman Z-Score places a company in a bankruptcy-risk zone, and the Fog Index measures text readability. The filings themselves show a company in transition. IFF completed the Pharma Solutions disposal group on May 1, 2025, sold the Nitrocellulose business on May 9, 2025, divested the Rene Laurent business on December 1, 2025, and closed the SCL disposal group on March 2, 2026. Those exits, with approximately $289 million of prior-year sales excluded from comparable results, explain much of the reported decline, which makes comparable currency neutral growth the more useful measure. Interest expense fell to $44 million from $71 million because of lower debt outstanding, a favorable trend. Against that, the risk factors cite ongoing antitrust and competition investigations with related class action lawsuits, possible Food Ingredients strategic alternatives, and a Productivity program that began with severance costs in early 2025. Readers may want to check the legal and debt notes for the amounts and timing of those items.

Catalyst.According to the MD&A for the quarter ended March 31, 2026, the main driver right now is volume growth across segments after portfolio divestitures. Comparable currency neutral sales rose 3%, while reported sales fell 4% to $2.741 billion because divestitures removed sales and currency added 4%. Health & Biosciences grew most, with comparable currency neutral sales up 5% on volume, and Food Ingredients rose 3%. Operating profit reached $273 million, compared with a loss of $903 million in the prior-year quarter, which included a $1.153 billion goodwill impairment tied to Food Ingredients. Gross margin improved to 37.1% from 36.4%.

Hidden risk.The filings show a tension a casual reader could miss: the 2025 annual operating result was a loss of $382 million, after $766 million of operating income in 2024. The risk-factor text says the company continues to evaluate strategic alternatives for its Food Ingredients segment, the unit that carried the $1.153 billion goodwill impairment. The excerpts do not explain the 2025 loss, so readers may want to check the impairment and restructuring notes. Other exposures include about 32% of 2025 sales from the 25 largest customers, a substantial debt load, and a possible tax liability from the N&B Transaction, for which IFF may need to indemnify DuPont.